Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan calls on Beijing to stop 'hybrid coercion' against Japan
11/15/2025 07:18 PM - Business
Taiwan, Poland sign economic cooperation pact
11/15/2025 06:55 PM - Politics
Ex-President Tsai calls for unity to build a better Taiwan
11/15/2025 05:18 PM - Cross-Strait
China's local bounty use shows intimidation with flexibility: Scholars
11/15/2025 04:45 PM - Business
Central bank denies Economist's allegation of an undervalued Taiwan dollar
11/15/2025 02:53 PM